ARKRAY MARKETING, INC.

Arkray Marketing, Inc. provides specialized medical diagnostic supply solutions, as inferred from its sole known contract under NAICS 325413, which corresponds to the manufacturing of in vitro diagnostic substances. The company supports the Defense Health Agency’s HCD West division, indicating direct engagement in the procurement and distribution of clinical diagnostic reagents, test kits, and associated laboratory consumables critical to military and veteran healthcare operations. While specific technical details are not disclosed, the nature of the award suggests expertise in managing the logistics and regulatory compliance of sensitive diagnostic products within federal healthcare supply chains, with an emphasis on just-in-time delivery and sole-source procurement protocols. The contractor’s primary agency relationship is with the Defense Health Agency, specifically its Western region, suggesting a focused role in supporting military medical facilities with diagnostic testing infrastructure. This relationship implies familiarity with DHA’s procurement frameworks, clinical workflow integration, and compliance with military health system standards for laboratory diagnostics. The company operates within the in vitro diagnostic manufacturing sector, a niche domain requiring adherence to FDA regulations, sterile production protocols, and chain-of-custody controls for clinical samples and reagents. Its market positioning is that of a specialized supplier to government healthcare systems, likely serving as a trusted vendor for diagnostic materials that require stringent quality assurance and rapid deployment in operational or expeditionary medical environments. Arkray Marketing, Inc. maintains a compact operational structure with no publicly disclosed certifications or geographic presence. Its government market positioning appears to be that of a niche provider, leveraging direct contracting pathways to deliver mission-critical diagnostic supplies to defense healthcare providers. The absence of broader certifications or multiple agency engagements suggests a highly targeted, capability-driven approach rather than broad-scale federal contracting.